The popularity of Sildenafil initially fueled a period of growth for major pharmaceutical companies, nevertheless recent changes present a murky outlook for shareholders. Generic competitors are eroding profits, and https://deaconufhv963473.ja-blog.com/41478102/sildenafil-and-pharma-a-risky-bet